Log in
Enquire now
‌

Affectis Pharmaceuticals

Drugs developer for the treatment of neurodegenerative and neuroinflammatory diseases.

OverviewStructured DataIssuesContributors

Contents

affectis.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biotechnology
Biotechnology
Pharmaceutical industry
Pharmaceutical industry
B2X
B2C
B2C
Number of Employees (Ranges)
11 – 50
Investors
EMBL Ventures
EMBL Ventures
Aescap Venture
Aescap Venture
Founded Date
2002
Total Funding Amount (USD)
21,000,000
Latest Funding Round Date
March 22, 2010
Country
Germany
Germany
Headquarters
Dortmund
Dortmund

Other attributes

Latest Funding Round Amount (USD)
350,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Affectis Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.